US Stocks
/
TScan Therapeutics, Inc. Share Price
TScan Therapeutics, Inc. Share Price

TScan Therapeutics, Inc. Share Price

NASDAQ: TCRX | Micro Cap
$0.23
+$0.00 (1.71%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

TScan Therapeutics, Inc. Stock Performance

Open
$0.24
Prev. Close
$0.23
Circuit Range
N/A
Day Range
$0.23 - $0.24
Year Range
$0.22 - $2.56
Volume
3,723
Average Traded
$0.23

TScan Therapeutics, Inc. Share Price Today

As of 11 October 2026, TScan Therapeutics, Inc.'s share price is $0.23. The stock opened at $0.24, compared to its previous close of $0.23. During today's trading session, TScan Therapeutics, Inc.'s share price traded between $0.23 and $0.24, with an average price of $0.24. Over the past 52 weeks, the stock has recorded a high of $2.56 and a low of $0.22. In terms of performance, TScan Therapeutics, Inc.'s share price has declined by 80.13% over the last six months and is down 88.02% on a year-on-year basis.

TScan Therapeutics, Inc. Share Price Chart

$0.23$0.24
L
Show Current Price
H

TScan Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$30.17M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.74
Revenue (TTM)
$10.33B
Return On Equity (TTM)
-170.55%
Profit Margin
-1256.24%
Debt to Equity
0.47
Quarterly Earnings Growth YoY
14.98%

TScan Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$2.51$2.57$0.98$1.05
Net Profit-$35.71-$22.98-$28.67-$30.36
Net Profit Margin-1422.71%-894.16%-2925.51%-2891.43%
Income ChangeN/A35.65%-24.76%-5.89%

TScan Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$13.54$21.05$2.82$10.33
Net Profit-$66.22-$89.22-$127.50-$129.77
Net Profit Margin-489.07%-423.85%-4521.28%-1256.24%
Income ChangeN/A-34.73%-42.91%-1.78%

About TScan Therapeutics, Inc.

TScan Therapeutics Inc is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.

TScan Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$0.32
$0.23
-28.13%
Sep 2026
$0.71
$0.32
-57.67%
Aug 2026
$0.75
$0.76
+1.34%
Jul 2026
$1.02
$0.75
-23.88%
Jun 2026
$1.07
$0.98
-9.68%
May 2026
$1.14
$1.08
-7.26%
Apr 2026
$1.04
$1.17
+16.53%
Mar 2026
$1.07
$1.00
-5.73%
Feb 2026
$1.04
$1.06
+3.90%
Jan 2026
$1.00
$1.02
+3.02%
Dec 2025
$1.11
$0.99
-11.16%
Nov 2025
$1.44
$1.12
-42.27%

TCRX Share Price FAQs

What is TScan Therapeutics, Inc. share price today?

chevron-up
TScan Therapeutics, Inc. share price today is $0.23 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of TScan Therapeutics, Inc. stock?

chevron-up
The 52 week high of TScan Therapeutics, Inc. stock is $2.56, while the 52 week low is $0.22 as of 10 Oct '26.

What is TCRX's market capitalisation today?

chevron-up
TCRX market capitalisation is $30.17M as of October 11, 2026, at 2:59 am IST.

What is TCRX's net income for the last quarter?

chevron-up
TCRX's net income for the last quarter is -30.36B USD.

What is the 5 year returns of TCRX?

chevron-up
The 5 year returns of TCRX is -97.35% as on 10 Oct '26.

What is the high & low stock price of TCRX today?

chevron-up
TCRX stock price hit a high of $0.24 and low of $0.23 as of 10 Oct '26.

Can I buy TCRX shares in India?

chevron-up
Yes. You can buy TCRX in India by opening an international trading account.